SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-008186
Filing Date
2014-02-06
Accepted
2014-02-06 20:35:23
Documents
2
Period of Report
2014-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8234
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 5347
  Complete submission text file 0001209191-14-008186.txt   15622
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address POSTBUS 5187 NAARDEN P7 1410
Business Address POSTBUS 5187 NAARDEN P7 1410 31 0 35 699 3000
Cooperatieve AAC LS U.A. (Reporting) CIK: 0001543352 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35443 | Film No.: 14581607

Mailing Address GOOIMEER 2-35 NAARDEN P7 1411DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411DC 31 35 6993000
Forbion Co-Investment II Cooperatief U.A. (Reporting) CIK: 0001598205 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35443 | Film No.: 14581606